Charles River raises annual profit view as it sells underperforming assets

Feb 25 (Reuters) - Contract drug developer Charles River Laboratories raised its 2026 profit forecast on Wednesday, after it announced the sales of some underperforming assets to peer IQVIA and ...
The Boston Globe

Take me to the river: The many ways to enjoy the Charles this summer

Marathoners know that the distance between Hopkinton and Boston is 26.2 miles. The Charles River, however, snakes 80 miles from its source at Hopkinton’s Echo Lake to the locks and dam where it spills ...
NBC Connecticut

Activist Elliott reaches key agreement with Charles River. Here are three ways to create value

Business: Charles River Laboratories is an early-stage contract research company. The company engages in laboratory animal medicine and science (research model technologies), and it has developed a ...
Nasdaq

Charles River Laboratories to Present at Evercore Healthcare Conference

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore 8th Annual Healthcare Conference on Wednesday, ...
Morningstar

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

Company maintains focus on driving forward New Approach Methodologies to enhance safety and efficacy testing Charles River Laboratories International, Inc. (NYSE: CRL) today announced the creation of ...